Donatella Vecchio

Via Enrico Melen 83
Genoa, 16142, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Reversing the Hypoxic Adaptive Response in Breast Cancer Cells through Small-Molecule Inhibition of Oncogenic MicroRNA-210.

Reversing the Hypoxic Adaptive Response in Breast Cancer Cells through Small-Molecule Inhibition of Oncogenic MicroRNA-210.

Journal: Journal of medicinal chemistry

Published: January 19, 2026

Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy.

Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy.

Journal: Journal of medicinal chemistry

Published: December 20, 2023

MYC-Associated Factor MAX is a Regulator of the Circadian Clock.

MYC-Associated Factor MAX is a Regulator of the Circadian Clock.

Journal: International journal of molecular sciences

Published: February 14, 2020

The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models.

The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models.

Journal: Critical reviews in oncology/hematology

Published: March 01, 2019

Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy.

Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy.

Journal: Scientific reports

Published: March 01, 2019

Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1].

Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1].

Journal: Scientific reports

Published: April 23, 2018

Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy.

Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy.

Journal: Current drug targets

Published: July 29, 2014

Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.

Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.

Journal: International journal of cancer

Published: June 25, 2014

Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.

Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.

Journal: International journal of cancer

Published: October 29, 2013

Accelerated repair and reduced mutagenicity of DNA damage induced by cigarette smoke in human bronchial cells transfected with E.coli formamidopyrimidine DNA glycosylase.

Accelerated repair and reduced mutagenicity of DNA damage induced by cigarette smoke in human bronchial cells transfected with E.coli formamidopyrimidine DNA glycosylase.

Journal: PloS one

Published: October 17, 2013

Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation.

Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation.

Journal: Journal of cancer research and clinical oncology

Published: February 09, 2012

Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.

Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.

Journal: Brain pathology (Zurich, Switzerland)

Published: January 20, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026